ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dexlansoprazole Sustained Release Capsule Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-25J14249
Home | Market Reports | Health| Health Conditions
Global Dexlansoprazole Sustained Release Capsule Market Research Report 2023
BUY CHAPTERS

Global Dexlansoprazole Sustained Release Capsule Market Research Report 2025

Code: QYRE-Auto-25J14249
Report
May 2025
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Par Pharm
TAKEDA PHARM
TWI PHARM

Dexlansoprazole Sustained Release Capsule Market Size

The global market for Dexlansoprazole Sustained Release Capsule was valued at US$ 329 million in the year 2024 and is projected to reach a revised size of US$ 470 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Dexlansoprazole Sustained Release Capsule Market

Dexlansoprazole Sustained Release Capsule Market

Dexlansoprazole sustained-release capsules were approved by the U.S. FDA in January 2009, under the trade name DEXILANT. For the treatment of heartburn caused by non-erosive gastroesophageal reflux disease (GERD), erosive esophagitis (EE) and maintenance treatment after healing of erosive esophagitis, all of which are administered once a day.
North American market for Dexlansoprazole Sustained Release Capsule is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dexlansoprazole Sustained Release Capsule is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Dexlansoprazole Sustained Release Capsule include TAKEDA PHARM, PAR PHARM, TWI PHARM, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dexlansoprazole Sustained Release Capsule, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dexlansoprazole Sustained Release Capsule.
The Dexlansoprazole Sustained Release Capsule market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dexlansoprazole Sustained Release Capsule market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dexlansoprazole Sustained Release Capsule manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dexlansoprazole Sustained Release Capsule Market Report

Report Metric Details
Report Name Dexlansoprazole Sustained Release Capsule Market
Accounted market size in year US$ 329 million
Forecasted market size in 2031 US$ 470 million
CAGR 5.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 30MG
  • 60MG
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company TAKEDA PHARM, PAR PHARM, TWI PHARM
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dexlansoprazole Sustained Release Capsule manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dexlansoprazole Sustained Release Capsule in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Dexlansoprazole Sustained Release Capsule Market growing?

Ans: The Dexlansoprazole Sustained Release Capsule Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Dexlansoprazole Sustained Release Capsule Market size in 2031?

Ans: The Dexlansoprazole Sustained Release Capsule Market size in 2031 will be US$ 470 million.

Who are the main players in the Dexlansoprazole Sustained Release Capsule Market report?

Ans: The main players in the Dexlansoprazole Sustained Release Capsule Market are TAKEDA PHARM, PAR PHARM, TWI PHARM

What are the Application segmentation covered in the Dexlansoprazole Sustained Release Capsule Market report?

Ans: The Applications covered in the Dexlansoprazole Sustained Release Capsule Market report are Hospital, Clinic

What are the Type segmentation covered in the Dexlansoprazole Sustained Release Capsule Market report?

Ans: The Types covered in the Dexlansoprazole Sustained Release Capsule Market report are 30MG, 60MG

Recommended Reports

Sustained Release Formulations

Digestive Disorder Drugs

Capsule and Formulation Markets

1 Dexlansoprazole Sustained Release Capsule Market Overview
1.1 Product Definition
1.2 Dexlansoprazole Sustained Release Capsule by Type
1.2.1 Global Dexlansoprazole Sustained Release Capsule Market Value Comparison by Type (2024 VS 2031)
1.2.2 30MG
1.2.3 60MG
1.3 Dexlansoprazole Sustained Release Capsule by Application
1.3.1 Global Dexlansoprazole Sustained Release Capsule Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Dexlansoprazole Sustained Release Capsule Market Size Estimates and Forecasts
1.4.1 Global Dexlansoprazole Sustained Release Capsule Revenue 2020-2031
1.4.2 Global Dexlansoprazole Sustained Release Capsule Sales 2020-2031
1.4.3 Global Dexlansoprazole Sustained Release Capsule Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dexlansoprazole Sustained Release Capsule Market Competition by Manufacturers
2.1 Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dexlansoprazole Sustained Release Capsule Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dexlansoprazole Sustained Release Capsule, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dexlansoprazole Sustained Release Capsule, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dexlansoprazole Sustained Release Capsule, Product Type & Application
2.7 Global Key Manufacturers of Dexlansoprazole Sustained Release Capsule, Date of Enter into This Industry
2.8 Global Dexlansoprazole Sustained Release Capsule Market Competitive Situation and Trends
2.8.1 Global Dexlansoprazole Sustained Release Capsule Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dexlansoprazole Sustained Release Capsule Players Market Share by Revenue
2.8.3 Global Dexlansoprazole Sustained Release Capsule Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dexlansoprazole Sustained Release Capsule Market Scenario by Region
3.1 Global Dexlansoprazole Sustained Release Capsule Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dexlansoprazole Sustained Release Capsule Sales by Region: 2020-2031
3.2.1 Global Dexlansoprazole Sustained Release Capsule Sales by Region: 2020-2025
3.2.2 Global Dexlansoprazole Sustained Release Capsule Sales by Region: 2026-2031
3.3 Global Dexlansoprazole Sustained Release Capsule Revenue by Region: 2020-2031
3.3.1 Global Dexlansoprazole Sustained Release Capsule Revenue by Region: 2020-2025
3.3.2 Global Dexlansoprazole Sustained Release Capsule Revenue by Region: 2026-2031
3.4 North America Dexlansoprazole Sustained Release Capsule Market Facts & Figures by Country
3.4.1 North America Dexlansoprazole Sustained Release Capsule Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dexlansoprazole Sustained Release Capsule Sales by Country (2020-2031)
3.4.3 North America Dexlansoprazole Sustained Release Capsule Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dexlansoprazole Sustained Release Capsule Market Facts & Figures by Country
3.5.1 Europe Dexlansoprazole Sustained Release Capsule Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dexlansoprazole Sustained Release Capsule Sales by Country (2020-2031)
3.5.3 Europe Dexlansoprazole Sustained Release Capsule Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dexlansoprazole Sustained Release Capsule Market Facts & Figures by Region
3.6.1 Asia Pacific Dexlansoprazole Sustained Release Capsule Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dexlansoprazole Sustained Release Capsule Sales by Region (2020-2031)
3.6.3 Asia Pacific Dexlansoprazole Sustained Release Capsule Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dexlansoprazole Sustained Release Capsule Market Facts & Figures by Country
3.7.1 Latin America Dexlansoprazole Sustained Release Capsule Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dexlansoprazole Sustained Release Capsule Sales by Country (2020-2031)
3.7.3 Latin America Dexlansoprazole Sustained Release Capsule Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dexlansoprazole Sustained Release Capsule Market Facts & Figures by Country
3.8.1 Middle East and Africa Dexlansoprazole Sustained Release Capsule Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dexlansoprazole Sustained Release Capsule Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dexlansoprazole Sustained Release Capsule Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dexlansoprazole Sustained Release Capsule Sales by Type (2020-2031)
4.1.1 Global Dexlansoprazole Sustained Release Capsule Sales by Type (2020-2025)
4.1.2 Global Dexlansoprazole Sustained Release Capsule Sales by Type (2026-2031)
4.1.3 Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2020-2031)
4.2 Global Dexlansoprazole Sustained Release Capsule Revenue by Type (2020-2031)
4.2.1 Global Dexlansoprazole Sustained Release Capsule Revenue by Type (2020-2025)
4.2.2 Global Dexlansoprazole Sustained Release Capsule Revenue by Type (2026-2031)
4.2.3 Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Type (2020-2031)
4.3 Global Dexlansoprazole Sustained Release Capsule Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dexlansoprazole Sustained Release Capsule Sales by Application (2020-2031)
5.1.1 Global Dexlansoprazole Sustained Release Capsule Sales by Application (2020-2025)
5.1.2 Global Dexlansoprazole Sustained Release Capsule Sales by Application (2026-2031)
5.1.3 Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Application (2020-2031)
5.2 Global Dexlansoprazole Sustained Release Capsule Revenue by Application (2020-2031)
5.2.1 Global Dexlansoprazole Sustained Release Capsule Revenue by Application (2020-2025)
5.2.2 Global Dexlansoprazole Sustained Release Capsule Revenue by Application (2026-2031)
5.2.3 Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Application (2020-2031)
5.3 Global Dexlansoprazole Sustained Release Capsule Price by Application (2020-2031)
6 Key Companies Profiled
6.1 TAKEDA PHARM
6.1.1 TAKEDA PHARM Company Information
6.1.2 TAKEDA PHARM Description and Business Overview
6.1.3 TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Sales, Revenue and Gross Margin (2020-2025)
6.1.4 TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Product Portfolio
6.1.5 TAKEDA PHARM Recent Developments/Updates
6.2 PAR PHARM
6.2.1 PAR PHARM Company Information
6.2.2 PAR PHARM Description and Business Overview
6.2.3 PAR PHARM Dexlansoprazole Sustained Release Capsule Sales, Revenue and Gross Margin (2020-2025)
6.2.4 PAR PHARM Dexlansoprazole Sustained Release Capsule Product Portfolio
6.2.5 PAR PHARM Recent Developments/Updates
6.3 TWI PHARM
6.3.1 TWI PHARM Company Information
6.3.2 TWI PHARM Description and Business Overview
6.3.3 TWI PHARM Dexlansoprazole Sustained Release Capsule Sales, Revenue and Gross Margin (2020-2025)
6.3.4 TWI PHARM Dexlansoprazole Sustained Release Capsule Product Portfolio
6.3.5 TWI PHARM Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dexlansoprazole Sustained Release Capsule Industry Chain Analysis
7.2 Dexlansoprazole Sustained Release Capsule Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dexlansoprazole Sustained Release Capsule Production Mode & Process Analysis
7.4 Dexlansoprazole Sustained Release Capsule Sales and Marketing
7.4.1 Dexlansoprazole Sustained Release Capsule Sales Channels
7.4.2 Dexlansoprazole Sustained Release Capsule Distributors
7.5 Dexlansoprazole Sustained Release Capsule Customer Analysis
8 Dexlansoprazole Sustained Release Capsule Market Dynamics
8.1 Dexlansoprazole Sustained Release Capsule Industry Trends
8.2 Dexlansoprazole Sustained Release Capsule Market Drivers
8.3 Dexlansoprazole Sustained Release Capsule Market Challenges
8.4 Dexlansoprazole Sustained Release Capsule Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Par Pharm
TAKEDA PHARM
TWI PHARM
List of Tables
 Table 1. Global Dexlansoprazole Sustained Release Capsule Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Dexlansoprazole Sustained Release Capsule Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Dexlansoprazole Sustained Release Capsule Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Dexlansoprazole Sustained Release Capsule Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Dexlansoprazole Sustained Release Capsule Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Dexlansoprazole Sustained Release Capsule Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Dexlansoprazole Sustained Release Capsule Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Dexlansoprazole Sustained Release Capsule, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dexlansoprazole Sustained Release Capsule, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dexlansoprazole Sustained Release Capsule, Product Type & Application
 Table 12. Global Key Manufacturers of Dexlansoprazole Sustained Release Capsule, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dexlansoprazole Sustained Release Capsule by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dexlansoprazole Sustained Release Capsule as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dexlansoprazole Sustained Release Capsule Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Dexlansoprazole Sustained Release Capsule Sales by Region (2020-2025) & (K Units)
 Table 18. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Region (2020-2025)
 Table 19. Global Dexlansoprazole Sustained Release Capsule Sales by Region (2026-2031) & (K Units)
 Table 20. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Region (2026-2031)
 Table 21. Global Dexlansoprazole Sustained Release Capsule Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Region (2020-2025)
 Table 23. Global Dexlansoprazole Sustained Release Capsule Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Region (2026-2031)
 Table 25. North America Dexlansoprazole Sustained Release Capsule Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Dexlansoprazole Sustained Release Capsule Sales by Country (2020-2025) & (K Units)
 Table 27. North America Dexlansoprazole Sustained Release Capsule Sales by Country (2026-2031) & (K Units)
 Table 28. North America Dexlansoprazole Sustained Release Capsule Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Dexlansoprazole Sustained Release Capsule Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Dexlansoprazole Sustained Release Capsule Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Dexlansoprazole Sustained Release Capsule Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Dexlansoprazole Sustained Release Capsule Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Dexlansoprazole Sustained Release Capsule Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Dexlansoprazole Sustained Release Capsule Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Dexlansoprazole Sustained Release Capsule Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Dexlansoprazole Sustained Release Capsule Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Dexlansoprazole Sustained Release Capsule Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Dexlansoprazole Sustained Release Capsule Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Dexlansoprazole Sustained Release Capsule Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Dexlansoprazole Sustained Release Capsule Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Dexlansoprazole Sustained Release Capsule Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Dexlansoprazole Sustained Release Capsule Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Dexlansoprazole Sustained Release Capsule Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Dexlansoprazole Sustained Release Capsule Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Dexlansoprazole Sustained Release Capsule Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Dexlansoprazole Sustained Release Capsule Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Dexlansoprazole Sustained Release Capsule Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Dexlansoprazole Sustained Release Capsule Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Dexlansoprazole Sustained Release Capsule Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Dexlansoprazole Sustained Release Capsule Sales (K Units) by Type (2020-2025)
 Table 51. Global Dexlansoprazole Sustained Release Capsule Sales (K Units) by Type (2026-2031)
 Table 52. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2020-2025)
 Table 53. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2026-2031)
 Table 54. Global Dexlansoprazole Sustained Release Capsule Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Dexlansoprazole Sustained Release Capsule Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Type (2020-2025)
 Table 57. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Type (2026-2031)
 Table 58. Global Dexlansoprazole Sustained Release Capsule Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Dexlansoprazole Sustained Release Capsule Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Dexlansoprazole Sustained Release Capsule Sales (K Units) by Application (2020-2025)
 Table 61. Global Dexlansoprazole Sustained Release Capsule Sales (K Units) by Application (2026-2031)
 Table 62. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Application (2020-2025)
 Table 63. Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Application (2026-2031)
 Table 64. Global Dexlansoprazole Sustained Release Capsule Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Dexlansoprazole Sustained Release Capsule Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Application (2020-2025)
 Table 67. Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Application (2026-2031)
 Table 68. Global Dexlansoprazole Sustained Release Capsule Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Dexlansoprazole Sustained Release Capsule Price (US$/Unit) by Application (2026-2031)
 Table 70. TAKEDA PHARM Company Information
 Table 71. TAKEDA PHARM Description and Business Overview
 Table 72. TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Product
 Table 74. TAKEDA PHARM Recent Developments/Updates
 Table 75. PAR PHARM Company Information
 Table 76. PAR PHARM Description and Business Overview
 Table 77. PAR PHARM Dexlansoprazole Sustained Release Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. PAR PHARM Dexlansoprazole Sustained Release Capsule Product
 Table 79. PAR PHARM Recent Developments/Updates
 Table 80. TWI PHARM Company Information
 Table 81. TWI PHARM Description and Business Overview
 Table 82. TWI PHARM Dexlansoprazole Sustained Release Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. TWI PHARM Dexlansoprazole Sustained Release Capsule Product
 Table 84. TWI PHARM Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Dexlansoprazole Sustained Release Capsule Distributors List
 Table 88. Dexlansoprazole Sustained Release Capsule Customers List
 Table 89. Dexlansoprazole Sustained Release Capsule Market Trends
 Table 90. Dexlansoprazole Sustained Release Capsule Market Drivers
 Table 91. Dexlansoprazole Sustained Release Capsule Market Challenges
 Table 92. Dexlansoprazole Sustained Release Capsule Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dexlansoprazole Sustained Release Capsule
 Figure 2. Global Dexlansoprazole Sustained Release Capsule Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dexlansoprazole Sustained Release Capsule Market Share by Type: 2024 & 2031
 Figure 4. 30MG Product Picture
 Figure 5. 60MG Product Picture
 Figure 6. Global Dexlansoprazole Sustained Release Capsule Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Dexlansoprazole Sustained Release Capsule Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Dexlansoprazole Sustained Release Capsule Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Dexlansoprazole Sustained Release Capsule Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Dexlansoprazole Sustained Release Capsule Sales (2020-2031) & (K Units)
 Figure 13. Global Dexlansoprazole Sustained Release Capsule Average Price (US$/Unit) & (2020-2031)
 Figure 14. Dexlansoprazole Sustained Release Capsule Report Years Considered
 Figure 15. Dexlansoprazole Sustained Release Capsule Sales Share by Manufacturers in 2024
 Figure 16. Global Dexlansoprazole Sustained Release Capsule Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Dexlansoprazole Sustained Release Capsule Players: Market Share by Revenue in Dexlansoprazole Sustained Release Capsule in 2024
 Figure 18. Dexlansoprazole Sustained Release Capsule Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Dexlansoprazole Sustained Release Capsule Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Dexlansoprazole Sustained Release Capsule Sales Market Share by Country (2020-2031)
 Figure 21. North America Dexlansoprazole Sustained Release Capsule Revenue Market Share by Country (2020-2031)
 Figure 22. United States Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Dexlansoprazole Sustained Release Capsule Sales Market Share by Country (2020-2031)
 Figure 25. Europe Dexlansoprazole Sustained Release Capsule Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Dexlansoprazole Sustained Release Capsule Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Dexlansoprazole Sustained Release Capsule Revenue Market Share by Region (2020-2031)
 Figure 33. China Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Dexlansoprazole Sustained Release Capsule Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Dexlansoprazole Sustained Release Capsule Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Dexlansoprazole Sustained Release Capsule Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Dexlansoprazole Sustained Release Capsule Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Dexlansoprazole Sustained Release Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Dexlansoprazole Sustained Release Capsule by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Dexlansoprazole Sustained Release Capsule by Type (2020-2031)
 Figure 52. Global Dexlansoprazole Sustained Release Capsule Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Dexlansoprazole Sustained Release Capsule by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Dexlansoprazole Sustained Release Capsule by Application (2020-2031)
 Figure 55. Global Dexlansoprazole Sustained Release Capsule Price (US$/Unit) by Application (2020-2031)
 Figure 56. Dexlansoprazole Sustained Release Capsule Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Dexlansoprazole Market Insights Forecast to 2030
Global Omeprazole Capsule Market Research Report 2024
Pharmaceutical Grade Dexlansoprazole Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ranitidine Hydrochloride Capsules Market Research Report 2024
Global Ranolazine Market Insights Forecast to 2030
Global Enteric Coated Softgels For Consumer Health Spplements Market Research Report 2024
Global Pantoprazole Sodium Enteric Coated Tablets Market Research Report 2024
Global Pantoprazole Injection Market Research Report 2024
Global Antiacid Hollow Capsules Market Research Report 2024
Global Pharmaceutical Antiacid Hollow Capsules Market Research Report 2024
Global Vonoprazan Fumarate Tablets Market Research Report 2024
Global Plant Enteric Coated Hollow Capsules Market Research Report 2024
Global Esomeprazole Capsule Market Research Report 2024
Global Pharmaceutical Plant Enteric Coated Hollow Capsules Market Research Report 2024
Global Plant Antiacid Hollow Capsules Market Research Report 2024
Global Felodipine Sustained Release Tablet Market Research Report 2024
Global Carbidopa and Levodopa Sustained release Tablets Market Research Report 2024
Global Compound Digestive Enzyme Capsule Market Research Report 2024
Global Omeprazole Magnesium Enteric Coated Tablets Market Research Report 2024
Global Lansoprazole for Injection Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions